LivaNova PLC - Ordinary Shares (LIVN): Price and Financial Metrics

LivaNova PLC - Ordinary Shares (LIVN)

Today's Latest Price: $51.03 USD

1.35 (2.72%)

Updated Nov 23 4:00pm

Add LIVN to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

LIVN Stock Summary

  • LIVN's went public 5.1 years ago, making it older than just 17.85% of listed US stocks we're tracking.
  • With a year-over-year growth in debt of 79.66%, LivaNova PLC's debt growth rate surpasses 86.49% of about US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for LIVN comes in at -15.85% -- higher than that of just 18.99% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to LivaNova PLC are OPK, OSMT, SANW, DDD, and DHX.
  • LIVN's SEC filings can be seen here. And to visit LivaNova PLC's official web site, go to

LIVN Stock Price Chart Interactive Chart >

Price chart for LIVN

LIVN Price/Volume Stats

Current price $51.03 52-week high $85.30
Prev. close $49.68 52-week low $33.40
Day low $49.78 Volume 335,450
Day high $51.33 Avg. volume 558,751
50-day MA $49.83 Dividend yield N/A
200-day MA $51.50 Market Cap 2.48B

LivaNova PLC - Ordinary Shares (LIVN) Company Bio

LivaNova PLC. offers cardiac surgery, cardiac rhythm management, and neuromodulation related products worldwide. The company was founded in 1987 and is based in London, England.

LIVN Latest News Stream

Event/Time News Detail
Loading, please wait...

LIVN Latest Social Stream

Loading social stream, please wait...

View Full LIVN Social Stream

Latest LIVN News From Around the Web

Below are the latest news stories about LivaNova PLC that investors may wish to consider to help them evaluate LIVN as an investment opportunity.

Artificial Cardiopulmonary Machine Market 2020-28 plays a crucial role of the heart and lungs during surgical procedures| LivaNova, Terumo CV Group, Getinge, Medtronic, Tianjin Medical, Braile Biomedica

Artificial heart-lung machine, commonly known as Artificial Cardiopulmonary Machine or cardiopulmonary bypass pump, is used to take the role of the heart and lungs during any cardiovascular surgical procedure. The Artificial Cardiopulmonary Machine Market report is an extensive, proficient and

OpenPR | September 28, 2020

LivaNova to Host Conference Call for Third Quarter 2020 Results

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC will host a conference call to discuss its third quarter 2020 results on Thursday, October 29, 2020 at 12 p.m. London (8 a.m. EDT).

Business Wire | September 28, 2020

LivaNova to Present at the Baird 2020 Global Healthcare Conference

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC announced Damien McDonald, CEO, will present at the Baird 2020 Global Healthcare Conference on Thursday, Sept. 10 at 9:05 a.m. EDT.

Business Wire | September 1, 2020

LivaNova to Present Autonomic Regulation Therapy Findings for Heart Failure During European Society of Cardiology Congress 2020

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova poster at ESC 2020 to share potential for autonomic regulation therapy to improve heart failure patients' long-term cardiovascular function.

Business Wire | August 12, 2020

Global Neurology Devices Market (2019 to 2025) - Featuring LivaNova, Magstim & Medtronic Among Others -

DUBLIN--(BUSINESS WIRE)--The "Neurology Devices Market 2019-2025" report has been added to's offering. The global neurology devices market is estimated to witness significant growth during the forecast period. Increasing demand for neurostimulation devices is one of the factors that are driving the market growth. Rising prevalence of neurological disorders, including Parkinson's and Alzheimer's disease has led the adoption of neurostimulation devices. In addition, rising

Business Wire | August 10, 2020

Read More 'LIVN' Stories Here

LIVN Price Returns

1-mo -4.53%
3-mo 10.91%
6-mo -7.74%
1-year -36.80%
3-year -40.86%
5-year -16.25%
YTD -32.35%
2019 -17.54%
2018 14.45%
2017 77.72%
2016 -24.25%
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8928 seconds.